1National institutes of health,National Heart,Lung and Blood Institutes.Global strategy for asthma management and prevention.Revised,2002
2Kemp JP,DeGraff AC Jr,Pearlman DS,et al.A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine.J Allergy Clin Immunol,1999;104:1189-1197
3O'Byrne PM,Barnes PJ,Rodriguez-Roisin R,et al.Low dose inhaled budesonide and formoterol in mild persistent asthma:the OPTIMA randomized trial.Am J Respir Crit Care Med,2000;164(8Pt1):1392-1399
4Calverley P,Pauwels R,Vestbo J,Jones P,et al.Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease:a randomised controlled trial.Lancet,2003;361(9356):449-456
5Howarth PH,Beckett P,Dahl R.The effect of long-acting beta2-agonists on airway inflammation in asthmatic patients.Respir Med,2000;94 Suppl F:S22-27
6Liam CK,Lim KH,Wong CM.Acceptance of the Accuhaler,a multi-dose powder inhaler,among asthmatic patients:a comparison with the pressurized metered-dose inhaler.Asian Pac J Allergy Immunol,2000;18:135-140
7Grembiale RD,Pelaia G,Naty S,et al.Comparison of the bronchodilating effects of inhaled formoterol,salmeterol and salbutamol in asthmatic patients.Pulm Pharmacol Ther,2002;15:463-469
8Kelloway JS,Wyatt R,DeMarco J,et al.Effect of salmeterol on patients adherence to their prescribed refills for inhaled corticosteroids.Ann Allergy Asthma Immunol,2000;84:324-322
9Robert H.Moore,Ayesha Khen.Long-acting inhaled β2-agonists in asthma therapy.Chest,1998;113:1095-1108
